The British Medical Journal requires immediate release of all COVID-19 vaccines and treatment data

The British Medical Journal (BMJ) requires the complete and immediate disclosure of all data related to the COVID-19 vaccine and treatment, and states that it is in the public interest.

The BMJ, a weekly peer-reviewed medical industry magazine published by the British Medical Association’s trade union, called for the data to be published in an editorial. Release on Wednesday.

“Despite the worldwide rollout of COVID-19 vaccines and therapies today, the anonymized participant-level data that underlies the trials of these new products are available to physicians, researchers, and the general public. People remain inaccessible and may remain in that state for the next few years, “said BMJ. “This cannot be morally defended in all trials, especially those involving major public health interventions.”

The BMJ also accused pharmaceutical companies of “making huge profits without sufficiently independent scrutiny of scientific claims,” ​​and Pfizer’s COVID vaccine trial “company-funded and Pfizer employees.” It was designed, executed, analyzed, and created by the staff. “

Pfizer, headquartered in New York, continues to retain its test data and will consider requesting such data from the major study completion date of May 15, 2023 to May 2025, 24 months later. Indicates that it will not start.

Meanwhile, the Food and Drug Administration (FDA) has asked judges to give them 75 years to produce all the data on Pfizer and BioNTech vaccines.

However, a judge earlier this month ordered the FDA to publish 12,000 pages of data used by the end of the month to make a decision on the approval of the Pfizer / BioNTech COVID-19 vaccine. The FDA also needs to publish Pfizer’s vaccine data at the following rates: 55,000 pages a month Until all requested pages are published.

The BMJ also said it indicates that AstraZeneca may be ready to accept requests for large numbers of data. Phase III study.. However, a company headquartered in Cambridge states that the timeline for such data is “request-by-request, and once the request for analysis, decision, anonymization, and sharing of the requested data or document is fully submitted, It can take up to a year. “

The Epoch Times is seeking comments from a spokesperson for Pfizer AstraZeneca.

“We are left with publications, but we do not have access to the underlying data on reasonable demands,” said the BMJ. “This is a concern for study participants, researchers, clinicians, journal editors, policy makers, and the general public. Journals that publish these major studies will have access to summary results quickly. We may argue that we faced a nasty dilemma between doing and supporting the highest ethical values ​​that support timely access to the underlying data. So there is no dilemma. Individual participant data anonymized from clinical trials should be available for independent scrutiny. “

The BMJ added that regulators exist to protect the health of the general public, not to “enrich them in line with the tone of affluent global companies.” So, “We need complete data transparency for every study. We need it. For the public good, and we need it now.”

In December, the US Centers for Disease Control and Prevention (CDC) was also sued by the Informed Consent Action Network (ICAN) for alleging improper withholding of safety data for the COVID-19 vaccine from US citizens. rice field.

ICAN is a COVID-19 vaccine by both the CDC and Biden administrations.Safe and effective.. “

The British Medical Journal, founded in 1840, is one of the oldest general medical journals in the world and is free to edit by the British Medical Association.

Catabella Roberts


Katabella Roberts is a reporter currently based in Turkey. She focuses primarily on the United States and covers the news and business of The Epoch Times.